Zika Virus IHR Emergency Committee
The IHR Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations met on five occasions from February to November 2016. Based on the advice provided to the WHO Director-General by the Committee, a Public Health Emergency of International Concern (PHEIC) was declared on 1 February 2016 and the Committee’s advice was issued as IHR Temporary Recommendations. The PHEIC was terminate by the Director-General on 18 November 2016.
Statements
Chair
Prof
David L.
Heymann
Professor of Infectious Disease Epidemiology, LSHTM, UK; Head, Centre on Global Health Security, Chatham House, London, UK; Former Assistant Director-General for Health Security, WHO HQ, Switzerland (Retired)
Learn more
Members
Dr Fernando Althabe
Director, Department of Maternal and Child Health Research, Institute for Clinical Effectiveness and Health Policy
Dr Kalpana Baruah
Joint Director, National Vector Borne Disease Control Programme, Ministry of Health and Family Welfare, New Delhi, India
Dr Silvia Bino
Associate Professor of Infectious Diseases; Head, Control of Infectious Diseases Department, Institute of Public Health, Tirana, Albania
Dr Anthony Evand
Chief, Aviation Medicine Section, International Civil Aviation Organization, Montreal, Canada
Professor David O. Freedman
Professor of Medicine and Epidemiology, University of Alabama at Birmingham, United States of America
Dr Abraham Hodgson
Director, Research and Development Division, Ghana Health Service, Accra, Ghana
Dr Nyoman Kandun
FETP Indonesia Program Director, Directorate General Disease Control and Environmental Health, Ministry of Health INDONESIA
Dr Ghazala Mahmud
Head of Department of Obstetrics and Gynaecology, Fazia Medical College, Islamabad, Pakistan
Dr K. U. Menon
Senior Consultant, Ministry of Communications and Information, Singapore
Prof. Michael Selgelid
Director, Centre for Human Bioethics, Monash University, Melbourne, Australia
Dr J. Erin Staples
Medical Epidemiologist at Arboviral Disease Branch, Division of Vector-borne Diseases, Centers for Disease Control and Prevention, United States of America
Dr Pedro Fernando da Costa Vasconcelos
Director, Evandro Chagas Institute; Director, National Reference Laboratory for Arboviruses; and Director, National Institute for Viral Hemorrhagic Fevers, Ananindeua, Brazil
Advisers
Prof. Claudia Torres Codeço
Head of the Scientific Computing Program, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Dr Férechté Encha-Razavi
Associate Professor, University of Paris-Déscartes, and Senior Consultant, Centres Pluridisciplinaires de Diagnostic Prénatal, Necker-Sick Children’s Hospital, Paris, France
Dr Dirk Glaesser
Director, Sustainable Development of Tourism, World Tourism Organization (UNWTO) SPAIN
Prof. Duane J. Gubler
Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-Nus Graduate Medical School, Singapore
Dr Kamran Khan
Associate Professor Faculty of Medicine, Division of Infectious Diseases, University of Toronto, and Clinician-Scientist St. Michael’s Hospital, Toronto, Canada
Dr Leonard Mboera
Chief Research Scientist and the Director of Information Technology and Communication, National Institute for Medical Research, Dar es Salaam,Tanzania
Dr James Meegan
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Office of Global Research, Bethesda, United States of America
Dr Maria Mercedes Muñoz Ramírez
Coordinator, Public Health Surveillance Group, Department of Epidemiology and Demography, Ministry of Health and Welfare, Bogota, Colombia
Dr Rafael Obregón
Chief, Communication for Development Section, United Nations Children’s Fund, New York, United States of America
Dr Annelies Wilder-Smith
Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore